Correction to: Postoperative Adjuvant Transarterial Infusion Chemotherapy with FOLFOX Could Improve Outcomes of Hepatocellular Carcinoma Patients with Microvascular Invasion: A Preliminary Report of a Phase III, Randomized Controlled Clinical Trial
Ann Surg Oncol. 2021 Dec;28(Suppl 3):874.
doi: 10.1245/s10434-021-09813-2.
1 Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People's Republic of China.
2 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer 3Medicine, Guangzhou, Guangdong, People's Republic of China.
3 Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People's Republic of China.
4 Department of Ultrasound, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People's Republic of China.
5 Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People's Republic of China.
6 Department of Radiology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People's Republic of China.
7 Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People's Republic of China. weiwei@sysucc.org.cn.
8 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer 3Medicine, Guangzhou, Guangdong, People's Republic of China. weiwei@sysucc.org.cn.
9 Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People's Republic of China. guorp@sysucc.org.cn.
10 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer 3Medicine, Guangzhou, Guangdong, People's Republic of China. guorp@sysucc.org.cn.